228 related articles for article (PubMed ID: 26880249)
1. IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.
Avnir Y; Watson CT; Glanville J; Peterson EC; Tallarico AS; Bennett AS; Qin K; Fu Y; Huang CY; Beigel JH; Breden F; Zhu Q; Marasco WA
Sci Rep; 2016 Feb; 6():20842. PubMed ID: 26880249
[TBL] [Abstract][Full Text] [Related]
2. Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.
Avnir Y; Tallarico AS; Zhu Q; Bennett AS; Connelly G; Sheehan J; Sui J; Fahmy A; Huang CY; Cadwell G; Bankston LA; McGuire AT; Stamatatos L; Wagner G; Liddington RC; Marasco WA
PLoS Pathog; 2014 May; 10(5):e1004103. PubMed ID: 24788925
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.
Cortina-Ceballos B; Godoy-Lozano EE; Téllez-Sosa J; Ovilla-Muñoz M; Sámano-Sánchez H; Aguilar-Salgado A; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Aparicio-Antonio R; Rodríguez MH; Martínez-Barnetche J
Genome Med; 2015 Nov; 7():124. PubMed ID: 26608341
[TBL] [Abstract][Full Text] [Related]
4. Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.
Avnir Y; Prachanronarong KL; Zhang Z; Hou S; Peterson EC; Sui J; Zayed H; Kurella VB; McGuire AT; Stamatatos L; Hilbert BJ; Bohn MF; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Goodall M; Jefferis R; Zhu Q; Kurt Yilmaz N; Schiffer CA; Marasco WA
Cell Rep; 2017 Dec; 21(11):3243-3255. PubMed ID: 29241550
[TBL] [Abstract][Full Text] [Related]
5. Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.
Sangesland M; Ronsard L; Kazer SW; Bals J; Boyoglu-Barnum S; Yousif AS; Barnes R; Feldman J; Quirindongo-Crespo M; McTamney PM; Rohrer D; Lonberg N; Chackerian B; Graham BS; Kanekiyo M; Shalek AK; Lingwood D
Immunity; 2019 Oct; 51(4):735-749.e8. PubMed ID: 31563464
[TBL] [Abstract][Full Text] [Related]
6. Structural and genetic basis for development of broadly neutralizing influenza antibodies.
Lingwood D; McTamney PM; Yassine HM; Whittle JR; Guo X; Boyington JC; Wei CJ; Nabel GJ
Nature; 2012 Sep; 489(7417):566-70. PubMed ID: 22932267
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.
Joyce MG; Wheatley AK; Thomas PV; Chuang GY; Soto C; Bailer RT; Druz A; Georgiev IS; Gillespie RA; Kanekiyo M; Kong WP; Leung K; Narpala SN; Prabhakaran MS; Yang ES; Zhang B; Zhang Y; Asokan M; Boyington JC; Bylund T; Darko S; Lees CR; Ransier A; Shen CH; Wang L; Whittle JR; Wu X; Yassine HM; Santos C; Matsuoka Y; Tsybovsky Y; Baxa U; ; Mullikin JC; Subbarao K; Douek DC; Graham BS; Koup RA; Ledgerwood JE; Roederer M; Shapiro L; Kwong PD; Mascola JR; McDermott AB
Cell; 2016 Jul; 166(3):609-623. PubMed ID: 27453470
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies.
Pushparaj P; Nicoletto A; Sheward DJ; Das H; Castro Dopico X; Perez Vidakovics L; Hanke L; Chernyshev M; Narang S; Kim S; Fischbach J; Ekström S; McInerney G; Hällberg BM; Murrell B; Corcoran M; Karlsson Hedestam GB
Immunity; 2023 Jan; 56(1):193-206.e7. PubMed ID: 36574772
[TBL] [Abstract][Full Text] [Related]
9. Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.
Sangesland M; Torrents de la Peña A; Boyoglu-Barnum S; Ronsard L; Mohamed FAN; Moreno TB; Barnes RM; Rohrer D; Lonberg N; Ghebremichael M; Kanekiyo M; Ward A; Lingwood D
Immunity; 2022 Sep; 55(9):1693-1709.e8. PubMed ID: 35952670
[TBL] [Abstract][Full Text] [Related]
10. Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging.
de Bourcy CF; Angel CJ; Vollmers C; Dekker CL; Davis MM; Quake SR
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1105-1110. PubMed ID: 28096374
[TBL] [Abstract][Full Text] [Related]
11. Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem.
Teo QW; Wang Y; Lv H; Tan TJC; Lei R; Mao KJ; Wu NC
Cell Rep; 2023 Nov; 42(11):113410. PubMed ID: 37976161
[TBL] [Abstract][Full Text] [Related]
12. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
13. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
14. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
Godoy-Lozano EE; Téllez-Sosa J; Sánchez-González G; Sámano-Sánchez H; Aguilar-Salgado A; Salinas-Rodríguez A; Cortina-Ceballos B; Vivanco-Cid H; Hernández-Flores K; Pfaff JM; Kahle KM; Doranz BJ; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Rodriguez MH; Martínez-Barnetche J
Genome Med; 2016 Feb; 8(1):23. PubMed ID: 26917418
[TBL] [Abstract][Full Text] [Related]
15. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
Wang G; Zhou F; Buchy P; Zuo T; Hu H; Liu J; Song Y; Ding H; Tsai C; Chen Z; Zhang L; Deubel V; Zhou P
J Infect Dis; 2014 Mar; 209(5):676-85. PubMed ID: 23911711
[TBL] [Abstract][Full Text] [Related]
16. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
18. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire.
Scheepers C; Shrestha RK; Lambson BE; Jackson KJ; Wright IA; Naicker D; Goosen M; Berrie L; Ismail A; Garrett N; Abdool Karim Q; Abdool Karim SS; Moore PL; Travers SA; Morris L
J Immunol; 2015 May; 194(9):4371-8. PubMed ID: 25825450
[TBL] [Abstract][Full Text] [Related]
19. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
[TBL] [Abstract][Full Text] [Related]
20. Erratum: IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.
Avnir Y; Watson CT; Glanville J; Peterson EC; Tallarico AS; Bennett AS; Qin K; Fu Y; Huang CY; Beigel JH; Breden F; Zhu Q; Marasco WA
Sci Rep; 2016 Apr; 6():23876. PubMed ID: 27125899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
